-
2024-512212-21-00
5
2017-11-28
Advanced hepatocellular carcinoma (HCC)
-
2024-516112-21-00
5
2017-11-20
Newly diagnosed acute myeloid leukaemia (AML), high risk myelodysplast
-
2023-506399-28-00
5
2017-11-08
Crohn's Disease
-
2024-515499-12-00
5
2017-10-02
Acute lymphoblastic leukemia
-
2023-504951-29-00
5
2017-07-27
Chron's Disease
-
2023-505699-31-00
5
2017-01-02
Ulcerative Colitis
-
2022-501763-40-00
5
2016-12-13
Pre-Exposure Prophylaxis of HIV-1 Infection
-
2023-509136-25-00
5
2015-07-16
Stage III melanoma (AJCC R0) with histologically confirmed cutaneous m
-
2024-510960-22-00
9
2015-06-25
gliobastoma
-
2024-514844-10-00
4
2010-03-18
Retinoblastoma
-
2024-514756-32-00
5
2007-03-19
High grade osteosarcoma
-
2025-521503-43-00
4
2026-02-12
Atopic dermatitis
-
2023-503823-24-01
3
2024-04-15
Systemic Sclerosis
-
2023-505846-24-00
4
2024-04-08
acute myeloid leukemia
-
2024-516672-16-00
5
2024-02-02
Multiple Sclerosis
-
2024-516671-33-00
5
2021-05-24
Amyotrophic Lateral Sclerosis
-
2023-506136-32-00
9
2020-10-12
Relapsed or Refractory B cell Precursor Acute Lymphoblastic Leukemia (
-
2024-511244-12-01
5
Amyotrophic Lateral Sclerosis
-
2024-518038-10-00
3
2025-05-12
None. Healthy subjects
-
2024-518733-29-00
6
2025-04-29
Severe acute pain
-
2023-508959-39-00
5
2025-02-20
Moderate to Severe Plaque Psoriasis
-
2024-514356-33-00
7
2025-02-11
"Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML),
-
2023-507563-19-00
5
2024-11-05
Thyroid eye disease
-
2024-516435-27-00
4
2024-11-05
High-risk myeloïd malignancies